Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Employs UNIarray Platform to Detect Protein Biomarkers Associated with Infectious Disease

Premium

German biotech companies Protagen and Mikrogen said this week that they are collaborating on the discovery of autoantibody signatures associated with infectious diseases.

The collaboration will use Protagen's UNIarray protein array platform to detect specific autoantibody signatures in serum.

"Within the scope of a mutual feasibility study performed with Mikrogen, we were able to show that infection-specific reactions of the immune system are accompanied by the generation of specific autoantibodies which are very useful for diagnostic developments," Peter Schulz-Knappe, CSO and executive vice president for diagnostics at Protagen, said in a statement.

Erwin Soutschek, co-founder and managing director of Mikrogen, said that the companies would jointly develop and market the biomarker panels for differential diagnosis of various infectious diseases.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.